InvestorsHub Logo
Followers 4
Posts 1198
Boards Moderated 0
Alias Born 10/03/2015

Re: DewDiligence post# 1147

Friday, 10/23/2015 8:21:42 PM

Friday, October 23, 2015 8:21:42 PM

Post# of 3021
Do you think ENTA have tried their cyclophilin inhibitors on NASH or Hep B? Do they have the technology/ip for diversification? Their proprietary pipeline looks like frozen for the last few years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News